Target intelligence / Profile preview

VAC14 antisense RNA 2 (VAC14-AS2)

Target: VAC14-AS2
Molecular classification: Other (antisense non-coding RNA)

Overview

VAC14 antisense RNA 2 is an antisense RNA transcript likely involved in the post-transcriptional regulation of the VAC14 gene. This non-coding RNA does not encode a protein or serve as a direct therapeutic target (for example, it is not a receptor, enzyme, transporter, or transcription factor). Instead, as with other antisense RNAs, it may function to modulate the stability, transcription, or translation of the overlapping or nearby VAC14 gene, which encodes a scaffold protein important in phosphoinositide regulation in endosomal membranes[4][5]. No literature supports a direct pharmacological or clinical relevance as a target.

Other names: VAC14-AS2VAC14 antisense RNA 2

Biological functions

Regulation of gene expression (likely regulates VAC14 expression)

Beyond the preview

Go deeper on VAC14 antisense RNA 2 (VAC14-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VAC14 antisense RNA 2 (VAC14-AS2).

Explore the full profile